Or hell....why not a GSK/Pfizer/Merck buy-out of Cytodyn.
$150 -$200b for a non-toxic cure.
Split @ 33% each.
Still a historical ROI @ year over year for each company.
(3)
(1)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.